BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31605563)

  • 1. A gut microbiota score predicting acute graft-versus-host disease following myeloablative allogeneic hematopoietic stem cell transplantation.
    Han L; Zhao K; Li Y; Han H; Zhou L; Ma P; Fan Z; Sun H; Jin H; Jiang Z; Liu Q; Peng J
    Am J Transplant; 2020 Apr; 20(4):1014-1027. PubMed ID: 31605563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis and Modeling of Risk Factors for Children with Intestinal Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation].
    Li XG; Xu YF; Wang RM; Yao T; Chen F; Lang T
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1516-1522. PubMed ID: 37846710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of the gut microbiome and clinical factors with acute GVHD in allogeneic HSCT recipients.
    Ilett EE; Jørgensen M; Noguera-Julian M; Nørgaard JC; Daugaard G; Helleberg M; Paredes R; Murray DD; Lundgren J; MacPherson C; Reekie J; Sengeløv H
    Blood Adv; 2020 Nov; 4(22):5797-5809. PubMed ID: 33232475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal dynamics of gut microbiota in the pathogenesis of acute graft-versus-host disease.
    Qi L; Peng J; Huang X; Zhou T; Tan G; Li F
    Cancer Med; 2023 Dec; 12(24):21567-21578. PubMed ID: 38053512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine supplement ameliorates murine aGVHD by modulation of gut microbiome and metabolome.
    Li X; Lin Y; Li X; Xu X; Zhao Y; Xu L; Gao Y; Li Y; Tan Y; Qian P; Huang H
    EBioMedicine; 2020 Nov; 61():103048. PubMed ID: 33039712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of Fecal Microbiota Transplantation to Prevent Acute GVHD: Analysis from a Phase II Trial.
    Rashidi A; Ebadi M; Rehman TU; Elhusseini H; Kazadi D; Halaweish H; Khan MH; Hoeschen A; Cao Q; Luo X; Kabage AJ; Lopez S; Holtan SG; Weisdorf DJ; Khoruts A; Staley C
    Clin Cancer Res; 2023 Dec; 29(23):4920-4929. PubMed ID: 37787998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Withaferin-A alleviates acute graft versus host disease without compromising graft versus leukemia effect.
    Kumar Gupta S; Gohil D; Dutta D; Panigrahi GC; Gupta P; Dalvi K; Khanka T; Yadav S; Kumar Kaushal R; Chichra A; Punatar S; Gokarn A; Mirgh S; Jindal N; Nayak L; Tembhare PR; Khizer Hasan S; Kumar Sandur S; Hingorani L; Khattry N; Gota V
    Int Immunopharmacol; 2023 Aug; 121():110437. PubMed ID: 37311352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The distribution of intestinal flora after hematopoietic stem cell transplantation in children.
    Tong L; Meng Y; Zhang L; Yu J; Dou Y
    Pediatr Transplant; 2024 Feb; 28(1):e14678. PubMed ID: 38148707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Intestinal Microbiota in Acute Graft-versus-Host Disease.
    Chen Y; Zhao Y; Cheng Q; Wu D; Liu H
    J Immunol Res; 2015; 2015():145859. PubMed ID: 26090477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Promise of Precision Nutrition for Modulation of the Gut Microbiota as a Novel Therapeutic Approach to Acute Graft-versus-host Disease.
    Lakshmanan AP; Deola S; Terranegra A
    Transplantation; 2023 Dec; 107(12):2497-2509. PubMed ID: 37189240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota diversity before allogeneic hematopoietic stem cell transplantation as a predictor of mortality in children.
    Masetti R; Leardini D; Muratore E; Fabbrini M; D'Amico F; Zama D; Baccelli F; Gottardi F; Belotti T; Ussowicz M; Fraczkiewicz J; Cesaro S; Zecca M; Merli P; Candela M; Pession A; Locatelli F; Prete A; Brigidi P; Turroni S
    Blood; 2023 Oct; 142(16):1387-1398. PubMed ID: 37856089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiota Predict Infections and Acute Graft-Versus-Host Disease After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation.
    Margolis EB; Alfaro GM; Sun Y; Dallas RH; Allison KJ; Ferrolino J; Ross HS; Davis AE; Jia Q; Turner P; Mackay V; Morin CE; Triplett BM; Klein EJ; Englund JA; Tang L; Hayden RT
    J Infect Dis; 2023 Aug; 228(5):627-636. PubMed ID: 37249910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leveraging machine learning for predicting acute graft-versus-host disease grades in allogeneic hematopoietic cell transplantation for T-cell prolymphocytic leukaemia.
    Chandra G; Wang J; Siirtola P; Röning J
    BMC Med Res Methodol; 2024 May; 24(1):112. PubMed ID: 38734644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Amniotic Membrane-Derived Mesenchymal Stem Cells Prevent Acute Graft-Versus-Host Disease in an Intestinal Microbiome-Dependent Manner.
    Bu X; Gao Y; Pan W; Liu L; Wang J; Yin Z; Ping B
    Transplant Cell Ther; 2024 Feb; 30(2):189.e1-189.e13. PubMed ID: 37939900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiota dynamics in a randomized trial of gut decontamination during allogeneic hematopoietic cell transplantation.
    Severyn CJ; Siranosian BA; Kong ST; Moreno A; Li MM; Chen N; Duncan CN; Margossian SP; Lehmann LE; Sun S; Andermann TM; Birbrayer O; Silverstein S; Reynolds CG; Kim S; Banaei N; Ritz J; Fodor AA; London WB; Bhatt AS; Whangbo JS
    JCI Insight; 2022 Apr; 7(7):. PubMed ID: 35239511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preservation of the fecal microbiome is associated with reduced severity of graft-versus-host disease.
    Burgos da Silva M; Ponce DM; Dai A; M Devlin S; Gomes ALC; Moore G; Slingerland J; Shouval R; Armijo GK; DeWolf S; Fei T; Clurman A; Fontana E; Amoretti LA; Wright RJ; Andrlova H; Miltiadous O; Perales MA; Taur Y; Peled JU; van den Brink MRM
    Blood; 2022 Dec; 140(22):2385-2397. PubMed ID: 35969834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota, microbiota-derived metabolites, and graft-versus-host disease.
    Yue X; Zhou H; Wang S; Chen X; Xiao H
    Cancer Med; 2024 Feb; 13(3):e6799. PubMed ID: 38239049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Research advances on short-chain fatty acids in gastrointestinal acute graft-
    Song X; Lao J; Wang L; Liu S
    Ther Adv Hematol; 2024; 15():20406207241237602. PubMed ID: 38558826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipocalin-2 expression identifies an intestinal regulatory neutrophil population during acute graft-versus-host disease.
    Czech M; Schneider S; Peltokangas N; El Khawanky N; Ghimire S; Andrieux G; Hülsdünker J; Krausz M; Proietti M; Braun LM; Rückert T; Langenbach M; Schmidt D; Martin I; Wenger V; de Vega E; Haring E; Pourjam M; Pfeifer D; Schmitt-Graeff A; Grimbacher B; Aumann K; Kircher B; Tilg H; Raffatellu M; Thiele Orberg E; Häcker G; Duyster J; Köhler N; Holler E; Nachbaur D; Boerries M; Gerner RR; Grün D; Zeiser R
    Sci Transl Med; 2024 Feb; 16(735):eadi1501. PubMed ID: 38381845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An alpha-defensin gene single nucleotide polymorphism modulates the gut microbiota and may alter the risk of acute graft-versus-host disease.
    Rashidi A; Herman A; Gomes ALC; Peled JU; Jenq RR; Brereton DG; Staley C; Blazar BR; Weisdorf DJ
    Br J Haematol; 2020 Jun; 189(5):926-930. PubMed ID: 32086815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.